MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Skincare
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
International Publications Spotlight MJNA’s Influence on U.N.’s Global CBD Policy Announcement

International Publications Spotlight MJNA’s Influence on U.N.’s Global CBD Policy Announcement

by adminTorusBrand | Dec 19, 2017 | Media Coverage

Following the WHO’s announcement of its stance that CBD not be considered a drug, several news reports covering the event highlighted MJNA’s role in the organization’s decision. Several international news publications covering last week’s World Health Organization...
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces International News Coverage on Benefits of CBD, U.N.’s Global CBD Policy

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces International News Coverage on Benefits of CBD, U.N.’s Global CBD Policy

by adminTorusBrand | Dec 18, 2017 | HempMeds Mexico, Press Releases

SAN DIEGO, Dec. 18, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, President of subsidiary HempMeds® Mexico, was recently featured in several international news...
WHO Makes its Recommendation: CBD Shouldn’t Be a Scheduled Substance

WHO Makes its Recommendation: CBD Shouldn’t Be a Scheduled Substance

by adminTorusBrand | Dec 14, 2017 | RaulWHO

After more than a month of deliberation, World Health Organization officials announced their recommendation that CBD should not be considered a drug. The World Health Organization announced today its recommendation that cannabidiol (CBD) should not be subject to...

United Nations Makes Recommendation Not To Schedule CBD as Drug After Medical Marijuana, Inc. Executive Spoke at World Health Organization Convention

by adminTorusBrand | Dec 14, 2017 | Press Releases

HempMeds® Mexico President Raúl Elizalde Influences Global Policy Recommendation SAN DIEGO, Dec. 14, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the World...
Choosing Between Medical Cannabis Consumption Options

Choosing Between Medical Cannabis Consumption Options

by adminTorusBrand | Dec 14, 2017 | Cannabis 101, The Basics

A complete overview of methods for consuming medical marijuana products. Medical marijuana patients are presented with a myriad of options when it comes to methods of consumption, including smokable options, vaporizers, edibles, and even topical applications. It can...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.